Covered recipient · General Payments record
IVAN ALEXANDER ESCUDERO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023
$180.48
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.48 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $34.81 | 1 |
| GlaxoSmithKline, LLC. | $31.19 | 2 |
| Lilly USA, LLC | $29.96 | 2 |
| Amgen Inc. | $17.78 | 1 |
| Axsome Therapeutics, Inc. | $17.72 | 1 |
| PFIZER INC. | $17.20 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.36 | 1 |
| SCPHARMACEUTICALS INC. | $15.46 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $180.48 | 10 |
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.81 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997216225 | CMS |
| Amgen Inc. | $17.78 | 11/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020590817 | CMS |
| Axsome Therapeutics, Inc. | $17.72 | 11/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056158029 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.36 | 11/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000092659 | CMS |
| GlaxoSmithKline, LLC. | $14.80 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002164897 | CMS |
| GlaxoSmithKline, LLC. | $16.39 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002162891 | CMS |
| Lilly USA, LLC | $14.96 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031593401 | CMS |
| Lilly USA, LLC | $15.00 | 12/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031495691 | CMS |
| PFIZER INC. | $17.20 | 11/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049846517 | CMS |
| SCPHARMACEUTICALS INC. | $15.46 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 995499856 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.